BMRA vs JNJ · rev $4.5M vs P/E 17, rev $49.37B
Biomerica Inc (BMRA) versus Johnson & Johnson (JNJ) — a side-by-side from cached financials, not a winner call.
Biomerica Inc (BMRA) is a medical devices company listed on US.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Latest reported BMRA revenue for 2026-05-31 was $4.5M. Net income was -$3.8M. Revenue was down 16.2% from 2025-05-31 to 2026-05-31. BMRA currently screens at market cap $8.0M.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
BMRA currently screens at market cap $8.0M. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Not investment advice. Open the BMRA and JNJ stock pages for the full models.
Not investment advice.